{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:41:55Z","timestamp":1790631715283,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,27]]},"abstract":"<jats:p>\n                    Ulcerative colitis (UC) is a chronic inflammatory bowel disease with a multifactorial etiology, including genetic, immunological, and environmental factors, as well as alterations in the gut microbiome and plasma metabolites. The interplay between these factors is complex and not fully elucidated, particularly regarding the potential mediation of metabolites in the relationship between gut microbiota and UC. We performed a Mendelian randomization (MR) study to investigate the causal associations between gut microbiota, plasma metabolites, and UC. The study utilized a two-sample MR approach to discern causal relationships among these factors. Genetic variants from genome-wide association studies served as instrumental variables in the MR analyses, conducted using the \u201cTwoSampleMR\u201d package in R software. We adhered to the fundamental assumptions of MR analyses, ensuring the validity of our causal inferences. Additionally, we incorporated a mediation analysis to assess the potential mediating role of plasma metabolites in the relationship between gut microbiota and UC. Our current study found the substantial relationship between certain gut microbial taxa and the development of UC. Indeed, we have identified 6 microbial taxa, including Genus\n                    <jats:italic toggle=\"yes\">Dorea<\/jats:italic>\n                    , Phylum Proteobacteria, Species\n                    <jats:italic toggle=\"yes\">Streptococcus parasanguinis<\/jats:italic>\n                    , Species\n                    <jats:italic toggle=\"yes\">Ruminococcus obeum<\/jats:italic>\n                    , Species\n                    <jats:italic toggle=\"yes\">Roseburia intestinalis<\/jats:italic>\n                    , and Order Lactobacillales, which were found to be causally related to UC. Seventy-three metabolites and metabolite ratios of were also causally associated with UC, and a mediation analysis revealed that metabolites such as stearoylcarnitine, 3-hydroxyoctanoylcarnitine, 1-arachidonoyl-GPE (20:4n6), 3-(3-hydroxyphenyl)propionate sulfate, and thioproline mediated the effects of gut microbiota on UC and hence might play roles in disease pathogenesis. This microbiota\u2013UC-specific MR study provides evidence for causal associations between specific gut microbiota and UC, potentially mediated through plasma metabolites. The findings give new perspectives on the causal nexus of the gut microbiota and plasma metabolites with UC, highlighting potential intervention targets for the disease. These findings call for confirmation in further research, together with investigation of the underlying mechanisms.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000042791","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T15:01:12Z","timestamp":1751295672000},"page":"e42791","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Gut microbiota causally affects ulcerative colitis by potential mediation of plasma metabolites: A Mendelian randomization study"],"prefix":"10.1097","volume":"104","author":[{"given":"Shidong","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Gastroenterological Surgery, Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People\u2019s Hospital, Beijing, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjing","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Pathology, Third Hospital, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjiang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People\u2019s Hospital, Beijing, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weisong","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People\u2019s Hospital, Beijing, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7823-8217","authenticated-orcid":false,"given":"Zhanlong","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People\u2019s Hospital, Beijing, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260813","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","article-title":"Ulcerative colitis.","volume":"402","author":"Le Berre","year":"2023","journal-title":"Lancet"},{"key":"R2-20260813","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12964-024-01611-z","article-title":"The development of probiotics and prebiotics therapy to ulcerative colitis: a therapy that has gained considerable momentum.","volume":"22","author":"Guo","year":"2024","journal-title":"Cell Commun Signal"},{"key":"R3-20260813","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S2468-1253(23)00441-7","article-title":"Microbiota therapeutics for inflammatory bowel disease: the way forward.","volume":"9","author":"Bethlehem","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R4-20260813","doi-asserted-by":"crossref","first-page":"9715","DOI":"10.3390\/ijms25179715","article-title":"Insights into gut dysbiosis: inflammatory diseases, obesity, and restoration approaches.","volume":"25","author":"Acevedo-Rom\u00e1n","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R5-20260813","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1016\/j.csbj.2022.03.038","article-title":"Gut microbial metabolome in inflammatory bowel disease: from association to therapeutic perspectives.","volume":"20","author":"Li","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"R6-20260813","doi-asserted-by":"crossref","first-page":"e2249866","DOI":"10.1002\/eji.202249866","article-title":"Emerging roles of host and microbial bioactive lipids in inflammatory bowel diseases.","volume":"53","author":"Kayama","year":"2023","journal-title":"Eur J Immunol"},{"key":"R7-20260813","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/jgh.16043","article-title":"Microbiome and metabolome in inflammatory bowel disease.","volume":"38","author":"Upadhyay","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"key":"R8-20260813","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization.","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"R9-20260813","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement.","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"R10-20260813","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41588-021-00992-y","article-title":"Effect of host genetics on the gut microbiome in 7,738 participants of the Dutch Microbiome Project.","volume":"54","author":"Lopera-Maya","year":"2022","journal-title":"Nat Genet"},{"key":"R11-20260813","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41588-022-01270-1","article-title":"Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases.","volume":"55","author":"Chen","year":"2023","journal-title":"Nat Genet"},{"key":"R12-20260813","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"R13-20260813","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R14-20260813","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/sim.6632","article-title":"Misunderstandings about Q and \u201cCochran\u2019s Q test\u201d in meta-analysis.","volume":"35","author":"Hoaglin","year":"2016","journal-title":"Stat Med"},{"key":"R15-20260813","first-page":"1961","article-title":"Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic.","volume":"45","author":"Bowden","year":"2016","journal-title":"Int J Epidemiol"},{"key":"R16-20260813","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R17-20260813","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40104-017-0164-6","article-title":"Efficient strategies for leave-one-out cross validation for genomic best linear unbiased prediction.","volume":"8","author":"Cheng","year":"2017","journal-title":"J Anim Sci Biotechnol"},{"key":"R18-20260813","doi-asserted-by":"crossref","first-page":"921546","DOI":"10.3389\/fimmu.2022.921546","article-title":"Two-sample Mendelian randomization analysis investigates causal associations between gut microbial genera and inflammatory bowel disease, and specificity causal associations in ulcerative colitis or crohn\u2019s disease.","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"R19-20260813","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","article-title":"Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases.","volume":"569","author":"Lloyd-Price","year":"2019","journal-title":"Nature"},{"key":"R20-20260813","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature24460","article-title":"Quantitative microbiome profiling links gut community variation to microbial load.","volume":"551","author":"Vandeputte","year":"2017","journal-title":"Nature"},{"key":"R21-20260813","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1002\/imt2.174","article-title":"Isolation of potentially novel species expands the genomic and functional diversity of Lachnospiraceae.","volume":"3","author":"Lin","year":"2024","journal-title":"Imeta"},{"key":"R22-20260813","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/1462-2920.12599","article-title":"Modelling the emergent dynamics and major metabolites of the human colonic microbiota.","volume":"17","author":"Kettle","year":"2015","journal-title":"Environ Microbiol"},{"key":"R23-20260813","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41591-018-0308-z","article-title":"Microbial network disturbances in relapsing refractory Crohn\u2019s disease.","volume":"25","author":"Yilmaz","year":"2019","journal-title":"Nat Med"},{"key":"R24-20260813","doi-asserted-by":"crossref","first-page":"e1800555","DOI":"10.1002\/biot.201800555","article-title":"Construction of a model culture system of human colonic microbiota to detect decreased lachnospiraceae abundance and butyrogenesis in the feces of ulcerative colitis patients.","volume":"14","author":"Sasaki","year":"2019","journal-title":"Biotechnol J"},{"key":"R25-20260813","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3390\/microorganisms8040573","article-title":"The controversial role of human gut lachnospiraceae.","volume":"8","author":"Vacca","year":"2020","journal-title":"Microorganisms"},{"key":"R26-20260813","doi-asserted-by":"crossref","first-page":"2292254","DOI":"10.1080\/19490976.2023.2292254","article-title":"The impact of gut microbiome enterotypes on ulcerative colitis: identifying key bacterial species and revealing species co-occurrence networks using machine learning.","volume":"16","author":"Wu","year":"2024","journal-title":"Gut Microbes"},{"key":"R27-20260813","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/metabo9020036","article-title":"Function, detection and alteration of acylcarnitine metabolism in hepatocellular carcinoma.","volume":"9","author":"Li","year":"2019","journal-title":"Metabolites"},{"key":"R28-20260813","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jcmgh.2023.09.005","article-title":"Enterobacteriaceae growth promotion by intestinal acylcarnitines, a biomarker of dysbiosis in inflammatory bowel disease.","volume":"17","author":"Lemons","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"R29-20260813","doi-asserted-by":"crossref","first-page":"709","DOI":"10.26599\/FSHW.2022.9250060","article-title":"Blautia producta displays potential probiotic properties against dextran sulfate sodium-induced colitis in mice.","volume":"13","author":"Mao","year":"2024","journal-title":"Food Sci Human Well"},{"issue":"Supplement_1","key":"R30-20260813","doi-asserted-by":"crossref","first-page":"i1035","DOI":"10.1093\/ecco-jcc\/jjac190.1056","article-title":"P926 Blautia Obeum aggravates colitis in a murine model.","volume":"17","author":"Lee","year":"2023","journal-title":"J Crohns Colitis"},{"key":"R31-20260813","doi-asserted-by":"crossref","first-page":"105071","DOI":"10.1016\/j.fitote.2021.105071","article-title":"3-(3-Hydroxyphenyl)propionic acid, a microbial metabolite of quercetin, inhibits monocyte binding to endothelial cells via modulating E-selectin expression.","volume":"156","author":"Feng","year":"2022","journal-title":"Fitoterapia"},{"key":"R32-20260813","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1021\/acs.chemrestox.0c00055","article-title":"Thioproline serves as an efficient antioxidant protecting human cells from oxidative stress and improves cell viability.","volume":"33","author":"Ham","year":"2020","journal-title":"Chem Res Toxicol"},{"key":"R34-20260813","doi-asserted-by":"crossref","first-page":"953962","DOI":"10.3389\/fcimb.2022.953962","article-title":"Composition and diverse differences of intestinal microbiota in ulcerative colitis patients.","volume":"12","author":"Zhu","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"R35-20260813","doi-asserted-by":"crossref","first-page":"757718","DOI":"10.3389\/fcimb.2021.757718","article-title":"Roseburia intestinalis: A beneficial gut organism from the discoveries in genus and species.","volume":"11","author":"Nie","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"R36-20260813","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/0016-5085(92)91727-L","article-title":"Tauro-\u03b2-muricholate preserves choleresis and prevents taurocholate-induced cholestasis in colchicine-treated rat liver.","volume":"102","author":"Katagiri","year":"1992","journal-title":"Gastroenterology"},{"key":"R37-20260813","doi-asserted-by":"crossref","first-page":"9351507","DOI":"10.1155\/2017\/9351507","article-title":"Proteobacteria: a common factor in human diseases.","volume":"2017","author":"Rizzatti","year":"2017","journal-title":"Biomed Res Int"},{"key":"R38-20260813","doi-asserted-by":"crossref","first-page":"748839","DOI":"10.3389\/fimmu.2022.748839","article-title":"Prevalence, abundance, and virulence of adherent-invasive escherichia coli in ulcerative colitis, colorectal cancer, and coeliac disease.","volume":"13","author":"L\u00f3pez-Siles","year":"2022","journal-title":"Front Immunol"},{"key":"R39-20260813","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.cgh.2019.09.022","article-title":"Association of alterations in intestinal microbiota with impaired psychological function in patients with inflammatory bowel diseases in remission.","volume":"18","author":"Humbel","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R40-20260813","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/gutjnl-2020-322630","article-title":"Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial.","volume":"70","author":"de Groot","year":"2021","journal-title":"Gut"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042791","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:06:10Z","timestamp":1786633570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":39,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042791","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]}}}